SESEN BIO INC's ticker is SESN and the CUSIP is 817763105. A total of 2 filers reported holding SESEN BIO INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $211,411 | +19.4% | 346,859 | -16.6% | 0.00% | – |
Q3 2022 | $177,000 | -38.5% | 415,890 | +16.9% | 0.00% | – |
Q2 2022 | $288,000 | +21.5% | 355,735 | -9.4% | 0.00% | – |
Q1 2022 | $237,000 | -63.0% | 392,713 | -50.0% | 0.00% | -100.0% |
Q4 2021 | $641,000 | +137.4% | 786,075 | +131.1% | 0.00% | – |
Q3 2021 | $270,000 | -49.7% | 340,181 | +192.5% | 0.00% | -100.0% |
Q2 2021 | $537,000 | +16.2% | 116,319 | -34.6% | 0.00% | 0.0% |
Q1 2021 | $462,000 | +507.9% | 177,821 | +216.1% | 0.00% | – |
Q4 2020 | $76,000 | -9.5% | 56,252 | -6.5% | 0.00% | – |
Q3 2020 | $84,000 | +8300.0% | 60,174 | +5296.8% | 0.00% | – |
Q2 2020 | $1,000 | -93.3% | 1,115 | -95.9% | 0.00% | – |
Q1 2020 | $15,000 | -44.4% | 26,915 | +2.5% | 0.00% | – |
Q4 2019 | $27,000 | +68.8% | 26,269 | +93.1% | 0.00% | – |
Q3 2019 | $16,000 | -36.0% | 13,606 | -18.2% | 0.00% | – |
Q2 2019 | $25,000 | -32.4% | 16,631 | -53.6% | 0.00% | – |
Q1 2019 | $37,000 | -51.9% | 35,862 | -33.7% | 0.00% | -100.0% |
Q4 2018 | $77,000 | – | 54,063 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP, LLC | 4,091,591 | $18,903,000 | 100.00% |
Schonfeld Strategic Advisors LLC | 3,828,200 | $17,687,000 | 0.19% |
Virtus ETF Advisers LLC | 52,632 | $243,000 | 0.10% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 711,500 | $3,287,000 | 0.06% |
WealthTrust Axiom LLC | 39,750 | $183,000 | 0.06% |
CAXTON ASSOCIATES LP | 84,801 | $392,000 | 0.04% |
Stratos Wealth Partners, LTD. | 352,500 | $1,629,000 | 0.04% |
ClariVest Asset Management LLC | 260,500 | $1,203,000 | 0.04% |
TWO SIGMA ADVISERS, LP | 2,766,318 | $12,780,000 | 0.03% |
TWO SIGMA INVESTMENTS, LP | 3,150,574 | $14,556,000 | 0.03% |